Skip to content

LIPOEDEME (L&M n°2 2026)
SUMMARY
EDITORIALS
PRATIQUES
ACTUALITÉS
RECHERCHE
VALEURS
ARCHIVES L&M

LIPOEDEME (L&M n°2 2026)
SUMMARY
EDITORIALS
PRATIQUES
ACTUALITÉS
RECHERCHE
VALEURS
ARCHIVES L&M

SCLÉROTHÉRAPIE (L&M n°3 2026)
EVF Phlebology Leaders
PIL Papers
Industry Leaders
Contact

SCLÉROTHÉRAPIE (L&M n°3 2026)
EVF Phlebology Leaders
PIL Papers
Industry Leaders
Contact

LIPOEDEME (L&M n°2 2026)
SUMMARY
EDITORIALS
PRATIQUES
ACTUALITÉS
RECHERCHE
VALEURS
ARCHIVES L&M

LIPOEDEME (L&M n°2 2026)
SUMMARY
EDITORIALS
PRATIQUES
ACTUALITÉS
RECHERCHE
VALEURS
ARCHIVES L&M

SCLÉROTHÉRAPIE (L&M n°3 2026)
EVF Phlebology Leaders
PIL Papers
Industry Leaders
Contact

SCLÉROTHÉRAPIE (L&M n°3 2026)
EVF Phlebology Leaders
PIL Papers
Industry Leaders
Contact

LM N° 2/ 2022. Another look. The new hyaluronic acid from AQ Skin Solutions. Véronique LENCZNAR.

L&M INTERVIEWS

Véronique LENCZNAR talks about

NEW HYALURONIC ACID

OF "AQ SKIN SOLUTIONS

Dr. Ahmed Al-Qahtani Immunologist & Founder of AQ Skin Solutions

Tagged Lm3 Interviews, Replay lm3

TO BE A LEADER IN ANTI-AGING MEDICINE
QUALITY COMMUNICATION
INNOVATIVE VISUAL OFFERS
STRONG DIGITAL COMMUNICATION FOR MANUFACTURERS
AN ORIGINAL AND SCIENTIFIC MULTIMEDIA EXPERTISE
THE L&M BRAND: A REFERENCE FOR AESTHETIC HEALTH PROFESSIONALS

Useful links

Contact
CGU
Blog

Social networks

Instagram Facebook-f

Website and mobile application designed by CAPROVE